Bimal Shah

Dr. Shah is a nationally recognized cardiologist who was most recently the Chief Operating Officer and Co-founder of Homeward. Previously, Dr. Shah became the Chief Medical Officer at Teladoc (NYSE: TDOC) after its merger with Livongo Health (NASDAQ: LVGO). In these roles he oversaw clinical product strategy, content, value and insight analytics, behavioral health strategy, clinical operations, quality and commercial enablement. Prior to Livongo, he was the Chief Medical Officer for Emerging Technology and Informatics and Service Line Vice President for Life Sciences at Premier Inc., (NASDAQ: PINC) where he led the P&L across all aspects of strategy, sales, marketing, product management, and operations.

Prior to Premier, Dr. Shah served as an Assistant Professor in both the Department of Medicine and Fuqua School of Business at Duke University where he led numerous research programs in the areas of health services research, implementation science, clinical trials, and registry analyses as well as an administrative role as the Director of Quality for the Department of Medicine. Dr. Shah graduated from the University of North Carolina – Chapel Hill with highest honors and earned both a MD and MBA from Duke University. He completed his residency in Internal Medicine at Stanford University before finishing a general cardiology fellowship at Duke University.

Bimal remains on faculty at Duke University and serves on the Board of Directors for Floreo. He is chair emeritus of the Board of Visitors at the Duke University School of Nursing and is also a current member of the Arts and Sciences Foundation Board of Directors at the University of North Carolina – Chapel Hill.

No relevant financial relationships to disclose.